Global Hepatitis C Drugs Market 2011-2015

95
-1

Published on

TechNavio's analysts forecast the Global Hepatitis C Drugs market to grow at a CAGR of 28 percent over the period 2011'2015. One of the key factors contributing to this market growth is the increasing prevalence of hepatitis C infection. The Global Hepatitis C Drugs market has also been witnessing the shift of treatments from multiple drug therapy to single drug therapy. However, the virus developing resistance to the drugs could pose a challenge to the growth of this market. TechNavio's report, the Global Hepatitis C Drugs Market 2011'2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Hepatitis C Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.Key vendors dominating this market space include GlaxoSmithKline plc, Merck & Co. Inc., Roche Holding Ltd., and Vertex Pharmaceuticals Ltd. Key questions answered in this report: What will the market size be in 2015 and at what rate will it grow'What key trends is this market subject to'What is driving this market'What are the challenges to market growth'Who are the key vendors in this market space'What are the opportunities and threats faced by each of these key vendors'What are the strengths and weaknesses of each of these key vendors'

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
95
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Global Hepatitis C Drugs Market 2011-2015

  1. 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Global Hepatitis C Drugs Market 2011-2015Published on May 2012 Report SummaryTechNavios analysts forecast the Global Hepatitis C Drugs market to grow at a CAGR of 28 percent over the period 20112015. Oneof the key factors contributing to this market growth is the increasing prevalence of hepatitis C infection. The Global Hepatitis C Drugsmarket has also been witnessing the shift of treatments from multiple drug therapy to single drug therapy. However, the virusdeveloping resistance to the drugs could pose a challenge to the growth of this market.TechNavios report, the Global Hepatitis C Drugs Market 20112015, has been prepared based on an in-depth analysis of the marketwith inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the GlobalHepatitis C Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the keyvendors operating in this market.Key vendors dominating this market space include GlaxoSmithKline plc, Merck & Co. Inc., Roche Holding Ltd., and VertexPharmaceuticals Ltd.Key questions answered in this report:What will the market size be in 2015 and at what rate will it growWhat key trends is this market subject toWhat is driving this marketWhat are the challenges to market growthWho are the key vendors in this market spaceWhat are the opportunities and threats faced by each of these key vendorsWhat are the strengths and weaknesses of each of these key vendors Table of Content01. Executive Summary02. Introduction03. Market Coverage04. Market Landscape05. Geographical Segmentation06. Key Leading Countries07. Rate of Incidence and Prevalence08. Vendor Landscape09. Buying Criteria10. Market Growth Drivers11. Drivers and their Impact12. Market Challenges13. Impact of Drivers and ChallengesGlobal Hepatitis C Drugs Market 2011-2015 (From Slideshare) Page 1/4
  2. 2. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!14. Market Trends15. Key Vendor Analysis15.1 Roche Holding Ltd.15.2 Merck & Co. Inc.15.3 GlaxoSmithKline plc15.4 Vertex Pharmaceuticals Ltd.16. Other Reports in this SeriesList of Exhibits:Exhibit 1: Global Hepatitis C Drugs Market 20112015 (US$ billion)Exhibit 2: Global Hepatitis C Drugs Market Segmentation by Therapy 2011Exhibit 3: Global Hepatitis C Drugs Market by Geographical Segmentation 2011Exhibit 4: Hepatitis C Infection by Source 2011Exhibit 5: Global Hepatitis C Drugs Market by Vendor Segmentation 2011Global Hepatitis C Drugs Market 2011-2015 (From Slideshare) Page 2/4
  3. 3. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Global Hepatitis C Drugs Market 2011-2015 Product Formats Please select the product formats and the quantity you require. 1 User License--USD 1 500.00 Quantity: _____ 3 User License--USD 1 700.00 Quantity: _____ 5 User License--USD 1 800.00 Quantity: _____ Corporate License--USD 2 500.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________Global Hepatitis C Drugs Market 2011-2015 (From Slideshare) Page 3/4
  4. 4. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93Global Hepatitis C Drugs Market 2011-2015 (From Slideshare) Page 4/4

×